Molecular and cellular effects of azilsartan: a new generation angiotensin II receptor blocker.

@article{Kajiya2011MolecularAC,
  title={Molecular and cellular effects of azilsartan: a new generation angiotensin II receptor blocker.},
  author={Takashi Kajiya and Christopher Ho and Jiaming Wang and Ryan F. Vilardi and Theodore W. Kurtz},
  journal={Journal of hypertension},
  year={2011},
  volume={29 12},
  pages={2476-83}
}
BACKGROUND Azilsartan medoxomil is a newly approved angiotensin receptor blocker (ARB) reported to lower 24-h blood pressure more effectively than maximally recommended doses of older ARBs. Although azilsartan is considered to be an unusually potent angiotensin II type 1 (AT1) receptor antagonist, little is known about the potential pleiotropic effects of… CONTINUE READING